Literature DB >> 11069457

Downregulation of class II molecules on epidermal Langerhans cells in Lyme borreliosis.

M Silberer1, F Koszik, G Stingl, E Aberer.   

Abstract

BACKGROUND: Borrelia burgdorferi can be isolated from the skin of patients with acrodermatitis chronica atrophicans (ACA), a late-stage manifestation of Lyme borreliosis; despite a marked T-cell infiltrate in lesional skin and high antibody titres in patients' sera.
OBJECTIVES: To determine whether antigen-presenting Langerhans cells (LCs), which reportedly show signs of injury in erythema chronicum migrans (ECM), the early stage of disease, are altered in ACA. PATIENTS/
METHODS: We studied the immunophenotype of cutaneous leucocytes on cryostat sections of lesional skin from both ECM and ACA patients.
RESULTS: The total number of CD1a+ cells evaluated by semiautomatic image analysis was lower in ECM (594 +/- 263 cells mm(-2) epidermis) than in ACA (835 +/- 317 cells mm(-2) epidermis). HLA-DR expression was remarkably downregulated on CD1a+ LCs to 29% in ECM and 18% in ACA, whereas in normal skin, most of the epidermal CD1a+ dendritic cells were HLA-DR+. The inflammatory infiltrate was mainly composed of CD68+ macrophages and CD45RO+ memory T cells, with a predominance of CD4+ helper T cells.
CONCLUSIONS: It is conceivable that the downregulation of major histocompatibility complex class II molecules on LC in both the early and late skin manifestations of Lyme borreliosis is indicative of a poorly effective anti-B. burgdorferi immune response and thus at least partly responsible for the insufficient elimination of this micro-organism from ACA skin.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11069457     DOI: 10.1046/j.1365-2133.2000.03776.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  7 in total

Review 1.  Smuggling across the border: how arthropod-borne pathogens evade and exploit the host defense system of the skin.

Authors:  Quentin Bernard; Benoit Jaulhac; Nathalie Boulanger
Journal:  J Invest Dermatol       Date:  2013-12-28       Impact factor: 8.551

2.  Borrelia burgdorferi-induced tolerance as a model of persistence via immunosuppression.

Authors:  Isabel Diterich; Carolin Rauter; Carsten J Kirschning; Thomas Hartung
Journal:  Infect Immun       Date:  2003-07       Impact factor: 3.441

3.  Borrelia burgdorferi binds to, invades, and colonizes native type I collagen lattices.

Authors:  Maria C Zambrano; Anastasia A Beklemisheva; Anton V Bryksin; Stuart A Newman; Felipe C Cabello
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

4.  Mycosis fungoides: is it a Borrelia burgdorferi-associated disease?

Authors:  S Miertusova Tothova; S Bonin; G Trevisan; G Stanta
Journal:  Br J Cancer       Date:  2006-03-27       Impact factor: 7.640

5.  Single-cell immunophenotyping of the skin lesion erythema migrans identifies IgM memory B cells.

Authors:  Ruoyi Jiang; Hailong Meng; Khadir Raddassi; Ira Fleming; Kenneth B Hoehn; Kenneth R Dardick; Alexia A Belperron; Ruth R Montgomery; Alex K Shalek; David A Hafler; Steven H Kleinstein; Linda K Bockenstedt
Journal:  JCI Insight       Date:  2021-06-22

6.  Lyme borreliosis and skin.

Authors:  Biju Vasudevan; Manas Chatterjee
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

7.  Co-inoculation of Borrelia afzelii with tick salivary gland extract influences distribution of immunocompetent cells in the skin and lymph nodes of mice.

Authors:  J Severinová; J Salát; Z Krocová; J Reznícková; H Demová; H Horká; J Kopecký
Journal:  Folia Microbiol (Praha)       Date:  2005       Impact factor: 2.629

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.